Latest filing published 29 May 2019 for Forte Biosciences, Inc., €4,881.
Insider track record
Douglas Jolly: trading record in brief
Douglas Jolly discloses dealings in Forte Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 8 December 2017 to 10 December 2018, the count stands at 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 29 May 2019: a share grant of €4,881, in Forte Biosciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Douglas Jolly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 703 shares@ US$8.1948.1% of flowCommon StockSEC:0001209191-19-033202:0
- 732 shares@ US$8.1951.9% of flowCommon StockSEC:0001209191-19-033202:1
- 739 shares@ US$8.5034.5% of flowCommon StockSEC:0001209191-17-065786:0
3 of 3 declarations
